市场调查报告书
商品编码
1380392
2023-2030 年全球颅骨穿孔器市场Global Cranial Perforators Market 2023-2030 |
预计在预测期内(2023-2030年),全球颅骨穿孔器市场将以 7.8% 的CAGR成长。由于脑肿瘤、脑外伤和脑出血等神经系统疾病的盛行率不断上升,对颅脑手术的需求正在稳定增加,预计将大幅增加对颅穿血管器的需求。据世界卫生组织称,约有 5000 万人患有癫痫症,使其成为全球最常见的神经系统疾病之一。
全球颅骨穿孔器市场按类型和最终用户进行细分。根据类型,市场分为可重复使用颅骨穿孔器和一次性颅骨穿孔器。此外,根据最终用户,市场分为医院和门诊手术中心。其中,一次性颅骨穿孔器子细分市场预计将占据相当大的市场份额,因为它消除了交叉污染和感染传播的风险,与需要再处理的可重复使用颅骨穿孔器相比,节省了宝贵的手术室时间。
其中,医院细分市场预计将在全球颅穿管市场中占据相当大的份额。 2022 年,医院细分市场占据最大市场份额,达到 60.4%。这是由于神经系统疾病患者住院人数的增加。根据美国国家生物技术资讯中心 (NCBI) 的数据,每年有 2,260 万人遭受神经损伤或疾病,其中 1,380 万人需要手术治疗。因此,神经科住院人数的增加增加了对手术所需设备的需求,从而推动了细分市场的成长。技术先进的颅骨穿孔器的可用性,加上有利的报销政策,可以进一步促进预测期内的细分市场成长。
全球颅骨穿孔器市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本) 、韩国和亚洲其他地区),以及世界其他地区(中东和非洲以及拉丁美洲)。其中,由于技术的不断发展,预计欧洲将在全球市场中占据显着份额。先进的颅穿支,加上优惠的报销政策,导致需要手术的疾病的盛行率和发生率不断上升。
在所有地区中,预计北美在预测期内将占据显着份额。市场成长归因于神经系统疾病发生率的上升、外科技术的进步、老年人口的增加、神经外科手术的持续研发。此外,监管部门的批准、优惠的报销政策和医疗保健基础设施也大大促进了市场的扩张。据脑动脉瘤基金会称,美国估计有 670 万人患有未破裂的脑动脉瘤,即每 50 人中就有 1 人患有未破裂脑动脉瘤。脑动脉瘤破裂占所有新兴中风的 3-5%。该地区先进的医学研究环境促进了医疗设备製造商、研究机构和医疗保健提供者之间的合作。这些合作伙伴关係推动了颅穿孔器的创新,重点是个人化医疗和患者专用仪器。
服务于全球颅骨穿孔器市场的主要公司包括: ACRA-CUT Inc.、American Surgical Co.、Integra LifeSciences Corp.、Nouvag AG、adeor Medical AG 等。市场参与者透过各种策略(包括併购、合作、合作、融资和新产品发布),为市场成长做出了巨大贡献,以保持市场竞争力。例如,2020年10月,adeor Medical AG与IMEDCARE建立合作伙伴关係,透过Imedcare在澳洲独家分销产品。
Title: Global Cranial Perforators Market Size, Share & Trends Analysis Report by Type (Reusable cranial perforators and Disposable cranial perforators), by End-User (Hospitals and Ambulatory Surgical Centers),Forecast Period (2023-2030).
The global cranial perforators market is anticipated to grow at a CAGR of 7.8% during the Forecast Period (2023-2030). The demand for cranial surgeries is steadily increasing owing to the rising prevalence of neurological disorders, including brain tumors, traumatic brain injuries, and intracerebral hemorrhages, which is projected to upsurge the demand for cranial perforators. According to the World Health Organization, around 50 million people have epilepsy, making it one of the most common neurological diseases globally.
The global cranial perforators market is segmented on the type, and end-user. Based on the type, the market is sub-segmented into reusable cranial perforators and disposable cranial perforators. Further, based on the end-user, the market is sub-segmented into hospitals and ambulatory surgical centers. Among the type, the disposable cranial perforators sub-segment is anticipated to hold a considerable share of the market, owing to the eliminating the risk of cross-contamination and infection transmission, saving valuable operating room time compared to reusable cranial perforators that require reprocessing.
Among the product, the hospitals sub-segment is expected to hold a considerable share of the global cranial perforators market. The hospitals segment accounted for the largest market share of 60.4% in 2022. This is due to the increasing hospitalization of patients with neurological disease conditions. According to the National Center for Biotechnology Information (NCBI), each year, 22.6 million people suffer from neurological injuries or disorders, of whom 13.8 million need surgery for their treatment. Thus, the increasing number of neurological hospital admission boost the demand for devices required for surgery, thereby driving segment growth. The availability of technologically advanced cranial perforators, coupled with favorable reimbursement policies, can further enhance segment growth during the forecast period.
The global cranial perforators market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Europe is anticipated to hold a prominent share of the market across the globe, owing to the increasing technologically advanced cranial perforators, coupled with favorable reimbursement policies, rising prevalence and incidence of diseases that require surgery.
Among all regions, North America is anticipated to hold a prominent share over the forecast period. The market growth is attributed to the rising incidence of neurological disorders, advancements in surgical techniques, the rising geriatric population, and continuous R&D in neurosurgical procedures. Moreover, regulatory approvals, favorable reimbursement policies, and healthcare infrastructure significantly contribute to the market's expansion. According to the Brain Aneurysm Foundation, an estimated 6.7 million people in the US have an unruptured brain aneurysm or 1 in 50 people. Ruptured brain aneurysms account for 3-5% of all new strokes. The region's advanced medical research landscape fosters collaborations between medical device manufacturers, research institutions, and healthcare providers. These partnerships drive innovation in cranial perforators, with an emphasis on personalized medicine and patient-specific instruments.
The major companies serving the global cranial perforators market include: ACRA-CUT Inc., American Surgical Co., Integra LifeSciences Corp., Nouvag AG, adeor medical AG, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2020, adeor medical AG entered into partnership with IMEDCARE to exclusively distribute products in Australia through Imedcare.